Nonproliferative Diabetic Retinopathy

• CLINICAL_TRIALS trial_result · 2025-07-28
  Clinical Trial Update: Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR) [Phase 2]

  Phase 2 study of EYP-1901 for nonproliferative diabetic retinopathy has completed. Results have been posted.

• CLINICAL_TRIALS research · 2025-06-18
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 [Phase 2]

  A Phase 2 clinical trial evaluating the efficacy and safety of orally administered VX-01 for diabetic retinopathy is currently recruiting.

• CLINICAL_TRIALS trial_result · 2024-05-30
  Clinical Trial Update: Intravitreal Bevacizumab for Diabetic Retinopathy [Phase 2, Phase 3]

  A Phase 2/3 trial evaluating intravitreal bevacizumab for diabetic retinopathy was terminated, with the study status listed as terminated.

• CLINICAL_TRIALS trial_result · 2024-05-30
  Clinical Trial Update: Changes in Macular Thickness After Patterns Scan Laser [Phase 4]

  A Phase 4 trial evaluating patterns scan laser for diabetic retinopathy reported changes in macular thickness and the study was terminated.

• CLINICAL_TRIALS trial_result · 2023-06-27
  Clinical Trial Update: The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) [Phase 2]

  Phase 2 trial update for AKB-9778 (razuprotafib), a Tie2 activator, in non-proliferative diabetic retinopathy has completed with results pos…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-04-22
  Clinical Trial Update: Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy [Phase 4]

  Phase 4 trial updates the effects of intravitreal ranibizumab on macular edema in nonproliferative diabetic retinopathy; results have been p…

• CLINICAL_TRIALS trial_result · 2019-11-21
  Clinical Trial Update: Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) [Phase 3]

  Phase 3 study evaluating intravitreal aflibercept for nonproliferative diabetic retinopathy has completed with posted results in 2019.

• CLINICAL_TRIALS research · 2017-08-24
  Clinical Trial Update: A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy [Phase 2]

  Phase 2 trial comparing Keluo Xin Capsule to placebo in patients with moderately severe to severe nonproliferative diabetic retinopathy; tri…

• CLINICAL_TRIALS trial_result · 2015-02-11
  Clinical Trial Update: Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

  This clinical trial update reports on a completed study evaluating progression of nonproliferative diabetic retinopathy in people with type …

• CLINICAL_TRIALS trial_result · 2015-01-22
  Clinical Trial Update: Diabetes Visual Function Supplement Study [NA]

  The Diabetes Visual Function Supplement Study sponsored by ZeaVision has completed, evaluating its effects in individuals with Type 1 or Typ…